This page shows the latest BRIC pharma markets news and features for those working in and with pharma, biotech and healthcare.
But while pharma's patent issues in the country persist, improvements to its regulatory system may be on the horizon, with plans from the Ministry of Health and Family Welfare to
Emerging markets remain a hot topic for executives and shareholders, with many large pharma companies citing success in Brazil as a critical factor for their long-term growth strategies. ... This article was originally published in the
Frost &Sullivan report highlights the difficulties for pharma working in BRIC markets. ... This is according to a new report by analysts Frost &Sullivan, which says that pharma firms expanding into emerging markets like Brazil, Russia, India and China (
More from news
Approximately 0 fully matching, plus 3 partially matching documents found.
BRIC healthcare markets are still an opportunity, but slowing growth and diverging healthcare policies mean pharma needs to employ nuanced, country-specific strategies. ... He added: “The hype about BRIC markets is cooler than it used to be.
As the BRIC foundations become firmly established, where next – and how soon – for those pharma companies seeking to exploit the developing markets? ... Beyond BRIC. It is increasingly clear that the global pharma sector, like many developed
The BRIC nations – Brazil, Russia, India and China – for so long the leading lights of the emerging markets movement, may soon need to relinquish their 'emerging' tag and become 'giants'. ... The BRIC nations are developing pharmaceutical markets
For so long the leading lights among pharma’s emerging markets, the BRIC nations may soon need to relinquish their ‘emerging’ tag as they continue on their transformation into economic powerhouses. ... Furthermore, as the BRIC foundations become
More from intelligence
Approximately 1 fully matching, plus 3 partially matching documents found.
Here at Cuttsy+Cuttsy, we believe in making the world a better place by bringing trusted, accessible information to all and...